Industry Asks EPA to Withdraw Dioxin Assessment, Cites Recent IRIS Mandate

ACC is asking EPA to withdraw its review of dioxin’s noncancer health effects, saying that recently passed legislation will require the agency to demonstrate how the assessment meets certain recommendations issued last April by the National Academy of Sciences (NAS; Washington). “To comply with Congress’s direction, EPA should withdraw the dioxin assessment from interagency review and take the necessary steps to implement the NAS recommendations,” says ACC president and CEO Cal Dooley in a recent letter to EPA administrator Lisa Jackson...

If you have already signed up for access to Chemical Week Regulatory Watch, please log in here.

Forgot your user ID or password?
Click here to have it sent to you.